Eriodictyol prevents early retinal and plasma abnormalities in streptozotocin-induced diabetic rats

Biochemical Pharmacology

Volumn 84, Issue 1, 2012, Pages 88-92

  Bucolo, Claudio ^a   Leggio, Gian Marco ^a   Drago, Filippo ^a   Salomone, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Antioxidant; Diabetes; Inflammation; Rat; Retina

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; ERIODICTYOL; GLUCOSE; INTERCELLULAR ADHESION MOLECULE 1; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; BLOOD RETINA BARRIER; CONTROLLED STUDY; DIABETIC RETINOPATHY; DOSE RESPONSE; DRUG EFFECT; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION;

ANIMALS; ANTIOXIDANTS; BLOOD-RETINAL BARRIER; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVANONES; LIPID PEROXIDATION; LIPID PEROXIDES; MALE; MOLECULAR STRUCTURE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RETINA;

EID: 84860687414     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2012.03.019     Document Type: Article

References (38)

1. D.M. Maahs, N.A. West, J.M. Lawrence, and E.J. Mayer-Davis Epidemiology of type 1 diabetes Endocrinol Metab Clin North Am 39 2010 481 497
2. R. Hazin, M. Colyer, F. Lum, and M.K. Barazi Revisiting diabetes 2000: challenges in establishing nationwide diabetic retinopathy prevention programs Am J Ophthalmol 152 2011 723 729
3. G.B. Arden, and S. Sivaprasad Hypoxia and oxidative stress in the causation of diabetic retinopathy Curr Diab Rev 7 2011 291 304
4. P. Pacher, I.G. Obrosova, J.G. Mabley, and C. Szabó Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies Curr Med Chem 12 2005 267 275
5. J. Tang, and T.S. Kern Inflammation in diabetic retinopathy Prog Retin Eye Res 30 2011 343 358
6. K. Miyamoto, S. Khosrof, S.E. Bursell, R. Rohan, T. Murata, and A.C. Clermont Prevention of leukostasis and vascular leakage in streptozotocin- induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition Proc Natl Acad Sci USA 96 1999 10836 10841
7. A.M. Joussen, V. Poulaki, N. Mitsiades, B. Kirchhof, K. Koizumi, and S. Döhmen Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-α suppression FASEB J 16 2002 438 440
8. J. Kusari, S.X. Zhou, E. Padillo, K.G. Clarke, and D.W. Gil Inhibition of vitreoretinal VEGF elevation and blood-retinal barrier breakdown in streptozotocin-induced diabetic rats by brimonidine J Invest Ophthalmol Vis Sci 51 2010 1044 1051
9. A.B. El-Remessey, M.A. Behzadian, G. Abou-Mohamed, T. Franklin, R.W. Caldwell, and R.B. Caldwell Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor Am J Pathol 162 2003 1995 2004
10. E. Iliaki, V. Poulaki, N. Mitsiades, C.S. Mitsiades, J.W. Miller, and S. Evangelos Role of 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy Invest Ophthalmol Vis Sci 50 2009 4898 4904
11. M. Takeda, F. Mori, A. Yoshida, A. Takamiya, S. Nakagomi, and E. Sato Constitutive nitric oxide synthase is associated with retinal vascular permeability in early diabetic rats Diabetologia 44 2001 1043 1050
12. K. Miyamoto, S. Khosrof, S.E. Bursell, Y. Moromizato, L.P. Aiello, and A. Clermont Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1) Am J Pathol 156 2000 1733 1739
13. Y. Miyake, K. Yamamoto, N. Tsujihara, and T. Osawa Protective effects of lemon flavonoids on oxidative stress in diabetic rats Lipids 33 1998 689 695
14. HannekenA, F.F. Lin, J. Johnson, and P. Maher Flavonoids protect human retinal pigment epithelial cells from oxidative-stress-induced death Invest Ophthalmol Vis Sci 47 2007 3164 3177
15. J. Johnson, P. Maher, and A. Hanneken The flavonoid, eriodictyol, induces long-term protection in ARPE-19 cells through its effects on Nrf2 activation and phase II gene expression Invest Ophthalmol Vis Sci 50 2009 2398 2406
16. J. Yin, J. Huang, C. Chen, N. Gao, F. Wang, and F.S. Yu Corneal complications in streptozocin-induced type I diabetic rats Invest Ophthalmol Vis Sci 52 2011 6589 6596
17. E.C. Leal, A. Manivannan, K. Hosoya, T. Terasaki, J. Cunha-Vaz, and A.F. Ambrósio Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy Invest Ophthalmol Vis Sci 48 2007 5257 5265
18. C. Bucolo, K.W. Ward, E. Mazzon, S. Cuzzocrea, and F. Drago Protective effects of a coumarin derivative in diabetic rats Invest Ophthalmol Vis Sci 50 2009 3846 3852
19. E.R. Lee, J.H. Kim, Y.J. Kang, and S.G. Cho The anti-apoptotic and anti-oxidant effect of eriodictyol on UV-induced apoptosis in keratinocytes Biol Pharm Bull 30 2007 32 37
20. F.M. Areias, A.C. Rego, C.R. Oliveira, and R.M. Seabra Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells Biochem Pharmacol 62 2001 111 118
21. J.J. Hendriks, H.E. de Vries, S.M. van der Pol, T.K. van den Berg, E.A. van Tol, and C.D. Dijkstra Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study Biochem Pharmacol 65 2003 877 885
22. E. Cho, J.M. Seddon, B. Rosner, W.C. Willett, and S.E. Hankinson Prospective study of intake of fruits, vegetables, vitamins, and carotenoids and risk of age-related maculopathy Arch Ophthalmol 122 2004 883 892
23. T.O. Obisesan, R. Hirsch, O.M. Kosoko, L. Carlson, and M. Parrott Moderate wine consumption is associated with decreased odds of developing age-related macular degeneration in NHANES-1 J Am Geriatr Soc 46 1998 1 7
24. S. Majumdar, and R. Srirangam Potential of the bioflavonoids in the prevention/treatment of ocular disorders Pharm Pharmacol 62 2010 951 965
25. P.H. Canter, and E. Ernst Anthocyanosides of Vaccinium myrtillus (bilberry) for night vision - a systematic review of placebo-controlled trials Surv Ophthalmol 49 2004 38 50
26. W. Kalt, J.B. Blumberg, J.E. McDonald, M.R. Vinqvist-Tymchuk, S.A. Fillmore, and B.A. Graf Identification of anthocyanins in the liver, eye, and brain of blueberry-fed pigs J Agric Food Chem 56 2008 705 712
27. H. Matsumoto, Y. Nakamura, H. Iida, K. Ito, and H. Ohguro Comparative assessment of distribution of blackcurrant anthocyanins in rabbit and rat ocular tissues Exp Eye Res 83 2006 348 356
28. J. Cai, K.C. Nelson, M. Wu, P. Sternberg Jr., and D.P. Jones Oxidative damage and protection of the RPE Prog Retin Eye Res 19 2000 205 221
29. A.Z. Fursova, O.G. Gesarevich, A.M. Gonchar, N.A. Trofimova, and N.G. Kolosova Dietary supplementation with bilberry extract prevents macular degeneration and cataracts in senesce-accelerated OXYS rats Adv Gerontol 16 2005 76 79
30. P. Maher, and A. Hanneken Flavonoids protect retinal ganglion cells from oxidative stress-induced death Invest Ophthalmol Vis Sci 46 2005 4796 4803
31. P.E. Milbury, B. Graf, J.M. Curran-Celentano, and J.B. Blumberg Bilberry (Vaccinium myrtillus) anthocyanins modulate heme oxygenase-1 and glutathione S-transferase-pi expression in ARPE-19 cells Invest Ophthalmol Vis Sci 48 2007 2343 2349
32. P. Talalay Chemoprotection against cancer by induction of phase 2 enzymes Biofactors 12 2000 1 4
33. S.K. Jain, R. McVie, J. Duett, and J.J. Herbst Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes Diabetes 38 1989 1539 1543
34. S.K. Jain, and R. McVie Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients Diabetes 48 1999 1550 1555
35. S.K. Jain, K. Kannan, G. Lim, R. McVie, and J.A. Bocchini Hyperketonemia increases TNF-α secretion in cultured U937 monocytes and type-1 diabetic patients Diabetes 51 2002 2287 2293
36. N. Patel Targeting leukostasis for the treatment of early diabetic retinopathy Cardiovasc Hematol Disord Drug Targets 9 2009 222 229
37. T.S. Kern Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy Exp Diab Res 2007 95 103
38. J.L. Evans, B.A. Maddux, and I.D. Goldfine The molecular basis for oxidative stress-induced insulin resistance Antioxid Redox Signal 7 2005 1040 1052